Literature DB >> 28104650

Genome Sequences of Diverse Human Cytomegalovirus Strains with Utility in Drug Screening and Vaccine Evaluation.

Kathleen Corcoran1, Carly J Sherrod1, Ellen F Perkowski1, Jordan Texier1, Fengsheng Li2, I-Ming Wang2, Michael McVoy3, Tong-Ming Fu2, Dirk P Dittmer4.   

Abstract

Cytomegalovirus displays genetic heterogeneity, which has implications for antiviral and vaccine development. Many studies have focused on laboratory isolates that have been extensively adapted for growth on fibroblasts. Here, we report whole-genome sequences for 10 human cytomegalovirus (HCMV) strains that readily grow on ARPE-19 human retinal pigment epithelial cells.
Copyright © 2017 Corcoran et al.

Entities:  

Year:  2017        PMID: 28104650      PMCID: PMC5255926          DOI: 10.1128/genomeA.01433-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Human cytomegalovirus (HCMV) is a herpesvirus in the subfamily Betaherpesvirinae, which, like all herpesviruses, establishes lifelong latent infections. Primary infection is usually mild to asymptomatic; however, for immunocompromised individuals, such as AIDS patients, transplant recipients, and developing fetuses, HCMV infection can have profound implications. HCMV isolates display genetic heterogeneity (1–3). Thus, genomic sequence data from a comprehensive collection of different isolates will facilitate vaccine and antiviral drug development. Ten HCMV strains were collected from a diverse set of sources. VHL/E was isolated from a duodenal biopsy specimen from a bone marrow transplant patient, propagated, and passaged in human umbilical vein endothelial cells (4, 5). VR3908 and VR7863 were isolated from urine samples from congenitally infected neonates and cultured on endothelial and epithelial cells (6). SUB-22 and SUB-24 were isolated from urine samples from congenitally infected neonates (S. Adler, unpublished data). VR5201, VR5235, and VR5022 were recovered from blood samples from solid organ transplant patients (6). NR was isolated from a serum sample from a kidney transplant patient and cloned into a bacterial artificial chromosome (H. Zhu, unpublished data). TB40/E was isolated from a throat swab from a bone marrow transplant patient, culture adapted, cloned into a bacterial artificial chromosome, and later modified by the addition of a green fluorescent protein (GFP) cassette (7, 8). Prior to sequencing, all strains were passaged three to five times on ARPE-19 human retinal pigment epithelial cells (9). Peak titers of culture supernatants ranged from 103 to 105 PFU/ml. Epithelial entry efficiency, assessed as relative infectivity on ARPE-19 cells versus MRC-5 fibroblasts, ranged from 10 to 80%. The VHL/E genome was assembled from 5,234,206 Illumina read pairs (n = 90). A de novo assembly was first generated using CLC Assembler. The Illumina reads were then read normalized and error corrected using BBMap tools (version 35.82), yielding 937,689 pairs with a mean distance of 454 bp that remapped to the de novo draft assembly. A total of 1,804 incorrectly oriented pairs and 3,953 distant pairs were excluded. The final consensus was constructed requiring >50% identity at each position, with a mean ± standard deviation (SD) coverage of 570.5× ± 64.3×. The nine remaining genomes were sequenced on a 454 GS Junior sequencer (Roche), according to the manufacturer’s protocol. Reads were trimmed and filtered for quality and read length using CLC Genomics Workbench version 9.0 (CLC bio). Filtered reads were used for de novo assembly, and contigs greater than 10 kbp were used to determine suitable reference sequences via NCBI nucleotide BLAST. Original trimmed reads were mapped to that reference (10). Reads that could nonspecifically map to a single position were ignored, and consensus sequences were generated with at least 25× coverage. Known repeat regions, with less than 25× coverage, were filled from corresponding references. These genome sequences provide a diverse collection of HCMV strains that retain epitheliotropism. This collection of sequences, representing strains from diverse sources and geographical regions, should facilitate studies to evaluate antiviral sensitivities or the impact of antigenic polymorphisms on vaccine efficacy.

Accession number(s).

The assembled sequences for HCMV are deposited in GenBank with the following accession numbers: NR, KX544831; SUB_24, KX544832; VR3908, KX544833; SUB_22, KX544834; VR5022, KX544835; VR5201, KX544836; VR5235, KX544837; VR7863, KX544838; TB40-E_UNC, KX544839; VHL/E_Merck_UNC, KX544841.
  10 in total

1.  Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells.

Authors:  W J Waldman; J M Sneddon; R E Stephens; W H Roberts
Journal:  J Med Virol       Date:  1989-08       Impact factor: 2.327

2.  Coding potential of laboratory and clinical strains of human cytomegalovirus.

Authors:  Eain Murphy; Dong Yu; Jane Grimwood; Jeremy Schmutz; Mark Dickson; Michael A Jarvis; Gabriele Hahn; Jay A Nelson; Richard M Myers; Thomas E Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Limits and patterns of cytomegalovirus genomic diversity in humans.

Authors:  Nicholas Renzette; Cornelia Pokalyuk; Laura Gibson; Bornali Bhattacharjee; Mark R Schleiss; Klaus Hamprecht; Aparecida Y Yamamoto; Marisa M Mussi-Pinhata; William J Britt; Jeffrey D Jensen; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

4.  ARPE-19, a human retinal pigment epithelial cell line with differentiated properties.

Authors:  K C Dunn; A E Aotaki-Keen; F R Putkey; L M Hjelmeland
Journal:  Exp Eye Res       Date:  1996-02       Impact factor: 3.467

5.  Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome.

Authors:  C Sinzger; K Schmidt; J Knapp; M Kahl; R Beck; J Waldman; H Hebart; H Einsele; G Jahn
Journal:  J Gen Virol       Date:  1999-11       Impact factor: 3.891

6.  Human cytomegalovirus UL131A, UL130 and UL128 genes are highly conserved among field isolates.

Authors:  F Baldanti; S Paolucci; G Campanini; A Sarasini; E Percivalle; M G Revello; G Gerna
Journal:  Arch Virol       Date:  2005-12-29       Impact factor: 2.574

7.  Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propagation in endothelial cells.

Authors:  W J Waldman; W H Roberts; D H Davis; M V Williams; D D Sedmak; R E Stephens
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E.

Authors:  Christian Sinzger; Gabriele Hahn; Margarete Digel; Ruth Katona; Kerstin Laib Sampaio; Martin Messerle; Hartmut Hengel; Ulrich Koszinowski; Wolfram Brune; Barbara Adler
Journal:  J Gen Virol       Date:  2008-02       Impact factor: 3.891

9.  A method enabling high-throughput sequencing of human cytomegalovirus complete genomes from clinical isolates.

Authors:  Steven Sijmons; Kim Thys; Michaël Corthout; Ellen Van Damme; Marnix Van Loock; Stefanie Bollen; Sylvie Baguet; Jeroen Aerssens; Marc Van Ranst; Piet Maes
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

10.  Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens.

Authors:  Charles Cunningham; Derek Gatherer; Birgitta Hilfrich; Katarina Baluchova; Derrick J Dargan; Marian Thomson; Paul D Griffiths; Gavin W G Wilkinson; Thomas F Schulz; Andrew J Davison
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

  10 in total
  4 in total

1.  Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.

Authors:  Xiaohong Cui; Daniel C Freed; Dai Wang; Ping Qiu; Fengsheng Li; Tong-Ming Fu; Lawrence M Kauvar; Michael A McVoy
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

2.  A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.

Authors:  Yaping Liu; Daniel C Freed; Leike Li; Aimin Tang; Fengsheng Li; Edward M Murray; Stuart P Adler; Michael A McVoy; Richard E Rupp; Diane Barrett; Xiaohua Ye; Ningyan Zhang; Karen Beck; Timothy Culp; Rituparna Das; Liping Song; Kalpit Vora; Hua Zhu; Dai Wang; Amy S Espeseth; Zhiqiang An; Luwy Musey; Tong-Ming Fu
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

3.  Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.

Authors:  Sha Ha; Fengsheng Li; Matthew C Troutman; Daniel C Freed; Aimin Tang; John W Loughney; Dai Wang; I-Ming Wang; Josef Vlasak; David C Nickle; Richard R Rustandi; Melissa Hamm; Pete A DePhillips; Ningyan Zhang; Jason S McLellan; Hua Zhu; Stuart P Adler; Michael A McVoy; Zhiqiang An; Tong-Ming Fu
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

4.  Association of CMV genomic mutations with symptomatic infection and hearing loss in congenital CMV infection.

Authors:  G Clement Dobbins; Amit Patki; Dongquan Chen; Hemant K Tiwari; Curtis Hendrickson; William J Britt; Karen Fowler; Jake Y Chen; Suresh B Boppana; Shannon A Ross
Journal:  BMC Infect Dis       Date:  2019-12-10       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.